of the Max - MDC
of the Max - MDC
of the Max - MDC
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
C/EBPα and C/EBPβ were found to recruit <strong>the</strong> ATP-dependent<br />
SWI/SNF chromatin remodeling complex to activate<br />
genes. Moreover, interaction with SWI/SNF is also required<br />
for C/EBP mediated proliferation arrest. The transcriptional<br />
function <strong>of</strong> C/EBPβ is unleashed by ras / MAP-kinase signaling<br />
and phosphorylation <strong>of</strong> <strong>the</strong> RD that causes a conformational<br />
change and releases <strong>the</strong> transactivation potential.<br />
This involves alteration <strong>of</strong> interaction with <strong>the</strong> MED23 subunit<br />
<strong>of</strong> “Mediator”, a complex that contacts <strong>the</strong> basic transcription<br />
machinery, including RNA Polymerase II.<br />
A chromatin function <strong>of</strong> <strong>the</strong> Myb (proto-)<br />
oncoprotein<br />
The classical retroviral Myb oncogene (v-myb) causes<br />
myeloblastosis (yet <strong>the</strong> name: Myb) and represents a<br />
mutated derivative <strong>of</strong> its cellular (c-Myb) counterpart which<br />
is essential for hematopoietic progenitor proliferation.<br />
The Myb protein harbors a DNA binding SANT-domain.<br />
Three distinct amino acid substitutions in <strong>the</strong> leukemic<br />
v-myb DNA binding SANT-domain are essential for <strong>the</strong><br />
leukemic potential <strong>of</strong> <strong>the</strong> oncoprotein that arrests progenitors<br />
on <strong>the</strong> myeloblast stage and maintains <strong>the</strong>ir selfrenewal.<br />
The Myb-SANT domain was since long supposed to harbor<br />
epigenetic functions. Yeast-two-hybrid screening revealed<br />
that <strong>the</strong> c-Myb SANT domain interacts specifically with <strong>the</strong><br />
N-terminal histone tails <strong>of</strong> H3 and H3.3 whereas v-Myb fails<br />
to do so. Moreover, <strong>the</strong> oncogenic mutations abrogate<br />
acetylation <strong>of</strong> H3, a requirement for collaborative activation<br />
<strong>of</strong> differentiation genes toge<strong>the</strong>r with C/EBP. This suggests<br />
that loss-<strong>of</strong>-function mutations in Myb converts it into a<br />
dominant-negative mutant, which causes leukemia.<br />
Importantly, pharmacologic enhancement <strong>of</strong> H3 acetylation<br />
(by an inhibitor <strong>of</strong> histone deacetylases) restored activation<br />
<strong>of</strong> differentiation genes and induced cell differentiation,<br />
implying that pharmacologic adjustment <strong>of</strong> an epigenetic<br />
mark can overcome <strong>the</strong> leukemic function <strong>of</strong> v-myb.<br />
Translational regulation <strong>of</strong> hematopoietic<br />
transcription factors<br />
Translational control has emerged as a major mechanism <strong>of</strong><br />
regulated gene expression. Both, C/EBPα and C/EBPβ transcripts<br />
harbor small upstream open reading frames (uORF)<br />
in <strong>the</strong>ir mRNAs that serve as relays for alternative initiation<br />
at downstream start sites. As a result, N-terminally truncated<br />
proteins with distinct biological functions are generated.<br />
In <strong>the</strong> case <strong>of</strong> C/EBPα and C/EBPβ, truncated forms sustain<br />
proliferation, whereas full length forms are strong<br />
inhibitors <strong>of</strong> cell division. Anaplastic large cell lymphoma<br />
and Hodgkin Lymphoma express large amounts <strong>of</strong> <strong>the</strong> truncated<br />
form <strong>of</strong> C/EBPβ. Rapamycin, an antibiotic that<br />
inhibits mTOR signaling, shuts down <strong>the</strong> truncated C/EBPβ<br />
is<strong>of</strong>orm and concomitantly inhibits growth in both types <strong>of</strong><br />
lymphomas. Ectopic expression <strong>of</strong> truncated C/EBPβ<br />
restored proliferation, suggesting truncated C/EBPβ as a<br />
translationally controlled oncogene in lymphoma.<br />
The stem cell and leukemia gene SCL/Tal1 also contains<br />
uORFs and is expressed as several is<strong>of</strong>orms. SCL is important<br />
for HSC biology and <strong>the</strong> SCL locus is found frequently<br />
translocated in childhood T-cell leukemia. Deletion <strong>of</strong> <strong>the</strong><br />
SCL uORF alters <strong>the</strong> expression <strong>of</strong> protein is<strong>of</strong>orms and modulats<br />
progenitor biology in colony assays, underscoring <strong>the</strong><br />
importance <strong>of</strong> uORF regulation in SCL biology.<br />
For both, C/EBPβ and SCL, we have now generated targeted<br />
mutations in <strong>the</strong> mouse that favor expression <strong>of</strong> distinct<br />
is<strong>of</strong>orms. Preliminary results show pr<strong>of</strong>ound biological and<br />
pathological alterations in <strong>the</strong>se animal strains.<br />
Canonical Wnt signaling in HSC<br />
Hematopoietic stem cells (HSC) respond to Wnt signaling<br />
but <strong>the</strong> functional role <strong>of</strong> β-catenin in self-renewal <strong>of</strong> HSCs<br />
remains controversial. The role <strong>of</strong> activated β-catenin in <strong>the</strong><br />
hematopoietic system was explored by a conditional gain<strong>of</strong>-function<br />
β-catenin gene in <strong>the</strong> mouse: Through a series<br />
<strong>of</strong> stem cell transplantation and functional assays, we<br />
demonstrated that excess <strong>of</strong> canonical Wnt signaling<br />
impairs HSCs and multi-lineage progenitor functions<br />
(Figure 2). Constitutive activation <strong>of</strong> β-catenin blocks<br />
differentiation and induces anemia, neutropenia, cytopenia,<br />
and death. Blood cell depletion was accompanied by<br />
complete failure <strong>of</strong> HSCs to differentiate into mature cells.<br />
Activation <strong>of</strong> β-catenin enforced cell cycle entry <strong>of</strong> HSCs,<br />
thus leading to exhaustion <strong>of</strong> long-term stem cells, yet<br />
preservation <strong>of</strong> short-term transit amplifying cells. Our data<br />
suggest that fine-tuned Wnt stimulation is essential for<br />
hematopoiesis and will be critical for any <strong>the</strong>rapeutic use.<br />
90 Cancer Research